TCL Archive In Congress: Societies, Advocates, Testify For Increases In Research Funding February 13, 1998
TCL Archive VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial May 30, 2014
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: NCI Ponders How Extra $40 Million Will Be Spent, Will Submit Plans to NCAB At Upcoming Meeting January 14, 1983
TCL Archive NCI Getting a Lot For a Little Money It Spends Overseas, International Program Director Says June 17, 1977
